Corvus Pharmaceuticals, Inc. (CRVS) Operating income 2016–2025
Corvus Pharmaceuticals, Inc. (CRVS) annual operating income history from SEC filings — each fiscal year as reported.
-$43.0MFY2025 · since FY2016: -$37.0M → -$43.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$43.0M | -56.0% |
| FY2024 | -$27.5M | -17.7% |
| FY2023 | -$23.4M | +28.1% |
| FY2022 | -$32.6M | +15.7% |
| FY2021 | -$38.6M | +11.7% |
| FY2020 | -$43.8M | +10.4% |
| FY2019 | -$48.9M | +0.7% |
| FY2018 | -$49.2M | +12.9% |
| FY2017 | -$56.5M | -52.9% |
| FY2016 | -$37.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice